Omnicell
JANUARY 10, 2023
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Omnicell
MARCH 27, 2023
As traditional hardware servers like Windows Server 2012 become obsolete with the end of support, the time is now to consider moving to the cloud. It's estimated the worldwide healthcare cloud computing market will increase at an annual growth rate of 17 percent by 2027.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
FEBRUARY 14, 2023
As traditional hardware servers like Windows Server 2012 become obsolete with the end of support, the time is now to consider moving to the cloud. It's estimated the worldwide healthcare cloud computing market will increase at an annual growth rate of 17 percent by 2027.
Board Vitals - Pharmacist
FEBRUARY 5, 2020
between 2012 and 2015. The study said, “Most of these specialists were advanced practitioners, physician assistants and nurse practitioners, delivering post-acute care.” The benefits offered by advanced level practitioners to practice is well documented as well.
PharmD Live
JANUARY 25, 2022
In the physician’s office, when you put electronic health records (EHRs) with algorithms and artificial intelligence into the hands of your team pharmacist, you have an overwhelming opportunity to improve clinical benefits and even greater opportunity to improve patient care. Comorbidities and Medicare patient risk.
The Pharmacist Blog
APRIL 25, 2015
All of my classmates for the class of 2012 were able to land community pharmacy jobs without residencies. If not financially, pharmacists will provide higher quality patient care through additional training. To top it off you are paid less than half a normal pharmacist salary. There is one caveat.
Hospital Pharmacy Europe
OCTOBER 14, 2024
With an introduction from Helena Beer, Dr Kunene shares first-hand insights into the clinical trial, the NHS Cancer Vaccine Launch Pad initiative and their potential for revolutionising patient care.
Expert insights. Personalized for you.
52 
Let's personalize your content